Researchmoz added Most up-to-date research on "Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Insights, Forecast to 2025" to its huge collection of research reports.
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.
The classification of Chemotherapy Induced Peripheral Neuropathy Treatment includes Calcium channel 2-delta ligands, Antidepressants, Opioids and Other Drugs. And the proportion of Opioids in 2017 is about 27%, and the proportion is in decreasing trend from 2013 to 2017.
Chemotherapy Induced Peripheral Neuropathy Treatment is widely used for CIPN cause by Platinum Agents, Taxanes, Vinca Alkaloids and Others. The most proportion of Chemotherapy Induced Peripheral Neuropathy Treatment is used in Platinum Agents, and the proportion in 2017 is 42%.
North America is the largest sales place, with a sales market share nearly 41% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 27%.
The global Chemotherapy Induced Peripheral Neuropathy Treatment market is valued at 1300 million US$ in 2017 and will reach 2150 million US$ by the end of 2025, growing at a CAGR of 6.5% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Chemotherapy Induced Peripheral Neuropathy Treatment market based on company, product type, end user and key regions.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1945944
This report studies the global market size of Chemotherapy Induced Peripheral Neuropathy Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chemotherapy Induced Peripheral Neuropathy Treatment in these regions.
This research report categorizes the global Chemotherapy Induced Peripheral Neuropathy Treatment market by top players/brands, region, type and end user. This report also studies the global Chemotherapy Induced Peripheral Neuropathy Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aptinyx
Asahi Kasei Pharma
Regenacy Pharmaceuticals
MAKScientific
Metys Pharmaceuticals
Nemus Bioscience
PledPharma
Sova Pharmaceuticals
DermaXon
Immune Pharmaceuticals
Kineta
Krenitsky Pharmaceuticals
PeriphaGen
Apexian Pharma
WinSanTor
Solasia Pharma
Market size by Product
Calcium Channel 2-delta Ligands
Antidepressants
Opioids
Others
Market size by End User
Platinum Agents
Taxanes
Vinca Alkaloids
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-chemotherapy-induced-peripheral-neuropathy-treatment-market-insights-forecast-to-2025-report.html/toc
The study objectives of this report are:
To study and analyze the global Chemotherapy Induced Peripheral Neuropathy Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Chemotherapy Induced Peripheral Neuropathy Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chemotherapy Induced Peripheral Neuropathy Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Chemotherapy Induced Peripheral Neuropathy Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Chemotherapy Induced Peripheral Neuropathy Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1945944
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.
The classification of Chemotherapy Induced Peripheral Neuropathy Treatment includes Calcium channel 2-delta ligands, Antidepressants, Opioids and Other Drugs. And the proportion of Opioids in 2017 is about 27%, and the proportion is in decreasing trend from 2013 to 2017.
Chemotherapy Induced Peripheral Neuropathy Treatment is widely used for CIPN cause by Platinum Agents, Taxanes, Vinca Alkaloids and Others. The most proportion of Chemotherapy Induced Peripheral Neuropathy Treatment is used in Platinum Agents, and the proportion in 2017 is 42%.
North America is the largest sales place, with a sales market share nearly 41% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 27%.
The global Chemotherapy Induced Peripheral Neuropathy Treatment market is valued at 1300 million US$ in 2017 and will reach 2150 million US$ by the end of 2025, growing at a CAGR of 6.5% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Chemotherapy Induced Peripheral Neuropathy Treatment market based on company, product type, end user and key regions.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1945944
This report studies the global market size of Chemotherapy Induced Peripheral Neuropathy Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chemotherapy Induced Peripheral Neuropathy Treatment in these regions.
This research report categorizes the global Chemotherapy Induced Peripheral Neuropathy Treatment market by top players/brands, region, type and end user. This report also studies the global Chemotherapy Induced Peripheral Neuropathy Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aptinyx
Asahi Kasei Pharma
Regenacy Pharmaceuticals
MAKScientific
Metys Pharmaceuticals
Nemus Bioscience
PledPharma
Sova Pharmaceuticals
DermaXon
Immune Pharmaceuticals
Kineta
Krenitsky Pharmaceuticals
PeriphaGen
Apexian Pharma
WinSanTor
Solasia Pharma
Market size by Product
Calcium Channel 2-delta Ligands
Antidepressants
Opioids
Others
Market size by End User
Platinum Agents
Taxanes
Vinca Alkaloids
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-chemotherapy-induced-peripheral-neuropathy-treatment-market-insights-forecast-to-2025-report.html/toc
The study objectives of this report are:
To study and analyze the global Chemotherapy Induced Peripheral Neuropathy Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Chemotherapy Induced Peripheral Neuropathy Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chemotherapy Induced Peripheral Neuropathy Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Chemotherapy Induced Peripheral Neuropathy Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Chemotherapy Induced Peripheral Neuropathy Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1945944
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
No comments:
Post a Comment